Lumiere Raises Pre-A for Epigenetic Editing
Lumiere Therapeutics, also known as Weiguang Gene in Chinese, completed a Pre-A financing of more than RMB100 million. Essential Capital and Huafang Capital co-led the round, joined by Yifeng Zhuohua, Junling Investment, the Guangzhou…
